Spectral Medical Inc. (TSX:EDT)
Canada · Delayed Price · Currency is CAD 1.390
-0.010 (-0.71%)
Jul 31, 2026, 2:33 PM EST
Spectral Medical Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -38.03 | -47.69 | -15.4 | -15.66 | -11.28 | -8.79 |
Depreciation & Amortization | 0.25 | 0.25 | 0.25 | 0.22 | 0.27 | 0.29 |
Stock-Based Compensation | 2.48 | 2.12 | 1.68 | 1.49 | 1.2 | 1.26 |
Other Adjustments | 31.31 | 35.99 | 3.65 | 3.64 | -0.67 | 0.29 |
Change in Receivables | -0.17 | 0.25 | -0.27 | 0.87 | -0.85 | 0.06 |
Changes in Inventories | -0.28 | -0.15 | 0.14 | -0.03 | -0.05 | -0.05 |
Changes in Accounts Payable | -0.82 | -0.27 | -0.05 | -0.27 | 1.57 | -0.62 |
Changes in Unearned Revenue | -0.66 | -0.17 | 1.36 | -0.64 | -0.66 | -0.66 |
Changes in Other Operating Activities | 0.12 | 0.15 | -0.17 | -0.35 | 0.57 | -0.49 |
Operating Cash Flow | -13.34 | -9.52 | -8.82 | -10.72 | -9.9 | -8.7 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | -0.03 | -0.19 | -0.03 | -0.48 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.16 |
Purchases of Intangible Assets | - | -0.2 | - | - | - | - |
Investing Cash Flow | -0.2 | -0.2 | -0.03 | -0.19 | -0.03 | -0.33 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 9.67 | 9.9 | 4.06 | 3.8 | - |
Net Long-Term Debt Issued (Repaid) | - | 9.67 | 9.9 | 4.06 | 3.8 | - |
Issuance of Common Stock | 3.51 | 3.4 | 1.15 | - | 4.11 | 13.41 |
Net Common Stock Issued (Repurchased) | 3.51 | 3.4 | 1.15 | - | 4.11 | 13.41 |
Other Financing Activities | -0.16 | -2.26 | -2.17 | 1.39 | 1.54 | -1.24 |
Financing Cash Flow | 10.92 | 10.8 | 8.88 | 5.44 | 9.46 | 12.17 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.06 |
Net Cash Flow | 0.25 | 1.08 | 0.04 | -5.46 | -0.48 | 3.14 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -13.34 | -9.52 | -8.85 | -10.91 | -9.93 | -9.18 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -483.30% | -390.01% | -386.92% | -682.48% | -595.86% | -460.12% |
Free Cash Flow Per Share | -0.05 | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 |
Levered Free Cash Flow | -36.57 | -38.21 | -4 | -12.85 | -5.81 | -10.79 |
Unlevered Free Cash Flow | -39.24 | -49.51 | -7.29 | -14.23 | -6.45 | -8.79 |